↓ Skip to main content

Dove Medical Press

Article Metrics

Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing–remitting multiple sclerosis?

Overview of attention for article published in Neuropsychiatric Disease and Treatment, October 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

blogs
1 blog
twitter
1 tweeter
facebook
1 Facebook page
googleplus
1 Google+ user
video
1 video uploader

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
16 Mendeley
Title
Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing–remitting multiple sclerosis?
Published in
Neuropsychiatric Disease and Treatment, October 2012
DOI 10.2147/ndt.s36771
Pubmed ID
Authors

Tunde Csepany, Mezei, Bereczki, Racz, Csiba

Abstract

Decreased relapse rate and slower disease progression have been reported with long-term use of immunomodulatory treatments (IMTs, interferon beta or glatiramer acetate) in relapsing-remitting multiple sclerosis. There are, however, patients who do not respond to such treatments, and they can be potential candidates for alternative therapeutic approaches.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 6%
Unknown 15 94%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 25%
Other 2 13%
Student > Master 2 13%
Professor 2 13%
Researcher 2 13%
Other 2 13%
Unknown 2 13%
Readers by discipline Count As %
Medicine and Dentistry 6 38%
Psychology 2 13%
Unspecified 1 6%
Agricultural and Biological Sciences 1 6%
Neuroscience 1 6%
Other 1 6%
Unknown 4 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 November 2012.
All research outputs
#2,816,731
of 22,459,507 outputs
Outputs from Neuropsychiatric Disease and Treatment
#380
of 2,955 outputs
Outputs of similar age
#18,259
of 154,712 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#2
of 12 outputs
Altmetric has tracked 22,459,507 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,955 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 154,712 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.